Related Experiment Video
Updated: Apr 19, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging
Elizabeth H Dibble1, Don C Yoo, Richard B Noto
1From the *Department of Diagnostic Imaging, Alpert Medical School of Brown University and Rhode Island Hospital; and †Department of Neurology, Alpert Medical School of Brown University and Butler Hospital, Providence, RI.
Abstract:
We report a case series of unusual I-ioflupane SPECT imaging findings. Three patients with atypical parkinsonian symptoms underwent I-ioflupane imaging to assist in diagnosis. The patients had complete or near-complete absence of striatal activity. The imaging deficit severity did not consistently correlate with the clinical deficit severity. These cases suggest that markedly abnormal uptake patterns may be seen with atypical parkinsonian syndromes. Further research is warranted to evaluate differences in I-ioflupane uptake patterns among the various parkinsonian syndromes.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Alterations in Muscle Tone lll

